Cargando…

MRI of Breast Tumor Initiating Cells Using the Extra Domain-B of Fibronectin Targeting Nanoparticles

The identification of breast tumor initiating cells (BTICs) is important for the diagnosis and therapy of breast cancers. This study was undertaken to evaluate whether the extra domain-B of fibronectin (EDB-FN) could be used as a new biomarker for BTICs and whether EDB-FN targeting superparamagnetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yujin, Kim, Hoe Suk, Park, Jinho, Li, Mulan, Tian, Lianji, Choi, YoonSeok, Choi, Byung Ihn, Jon, Sangyong, Moon, Woo Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063982/ https://www.ncbi.nlm.nih.gov/pubmed/24955145 http://dx.doi.org/10.7150/thno.8343

Ejemplares similares

Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors
por: Li, Mulan, et al.
Publicado: (2012)

Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma
por: Saw, Phei Er, et al.
Publicado: (2021)

Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells
por: Kim, Hoe Suk, et al.
Publicado: (2015)

In vivo Tracking of Dendritic Cell using MRI Reporter Gene, Ferritin
por: Kim, Hoe Suk, et al.
Publicado: (2015)

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
por: Martín-Otal, Celia, et al.
Publicado: (2022)

Expression of Fibronectin Isoforms in Human Breast Tissue: Production of Extra Domain A(+)/Extra Domain B(+) by Cancer Cells and Extra Domain A(+) by Stromal Cells
por: Matsumoto, Ei‐ichi, et al.
Publicado: (1999)

Investigation of discriminant metabolites in tamoxifen-resistant and choline kinase-alpha-downregulated breast cancer cells using (1)H-nuclear magnetic resonance spectroscopy
por: Kim, Hoe Suk, et al.
Publicado: (2017)

Fibronectin Extra Domain A Promotes Liver Sinusoid Repair following Hepatectomy
por: Sackey-Aboagye, Bridget, et al.
Publicado: (2016)

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
por: Lieverse, Relinde I. Y., et al.
Publicado: (2020)

Correction: Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
Publicado: (2022)

CAR-T-Cell Therapy for Solid Tumors Positive for Fibronectin Extra Domain B
por: Zhang, Zhijie, et al.
Publicado: (2022)

Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery
por: Yu, Mikyung, et al.
Publicado: (2018)

Lack of Fibronectin Extra Domain A Alternative Splicing Exacerbates Endothelial Dysfunction in Diabetes
por: Gortan Cappellari, Gianluca, et al.
Publicado: (2016)

Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent
Publicado: (1989)

Fibroblast-like synovial cell production of extra domain A fibronectin associates with inflammation in osteoarthritis
por: Kragstrup, Tue W., et al.
Publicado: (2019)

Fibronectin extra domain a limits liver dysfunction and protects mice during acute inflammation()
por: Venu, Vivek Krishna Pulakazhi, et al.
Publicado: (2023)

Real-Time Imaging of the Epithelial-Mesenchymal Transition Using microRNA-200a Sequence-Based Molecular Beacon-Conjugated Magnetic Nanoparticles
por: Choi, YoonSeok, et al.
Publicado: (2014)

Fibronectin containing alternatively spliced extra domain A interacts at the central and c-terminal domain of Toll-like receptor-4
por: Gupta, Shubhangi, et al.
Publicado: (2022)

Cellular Fibronectin Containing Extra Domain A Causes Insulin Resistance via Toll-like Receptor 4
por: Rajak, Sangam, et al.
Publicado: (2020)

Treating solid tumors with TCR-based chimeric antigen receptor targeting extra domain B-containing fibronectin
por: Zhang, Zhijie, et al.
Publicado: (2023)

Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
por: Yu, Mi Kyung, et al.
Publicado: (2012)

Fibronectin extra domain A (FN-EDA) elevates intraocular pressure through Toll-like receptor 4 signaling
por: Roberts, Amanda L., et al.
Publicado: (2020)

Fibronectin extra domain A (FN-EDA) causes glaucomatous trabecular meshwork, retina, and optic nerve damage in mice
por: Mavlyutov, Timur A., et al.
Publicado: (2022)

Life Comparative Analysis of Energy Consumption and CO(2) Emissions of Different Building Structural Frame Types
por: Kim, Sangyong, et al.
Publicado: (2013)

Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models
por: El-Emir, E, et al.
Publicado: (2007)

Polymer Thin Film Promotes Tumor Spheroid Formation via JAK2-STAT3 Signaling Primed by Fibronectin-Integrin α5 and Sustained by LMO2-LDB1 Complex
por: Seo, Sunyoung, et al.
Publicado: (2022)

Fibronectin mediates Treponema pallidum cytadherence through recognition of fibronectin cell-binding domain
Publicado: (1985)

The Extra Domain A of Fibronectin Increases VEGF-C Expression in Colorectal Carcinoma Involving the PI3K/AKT Signaling Pathway
por: Xiang, Lisha, et al.
Publicado: (2012)

Alternative Splicing of the Angiogenesis Associated Extra-Domain B of Fibronectin Regulates the Accessibility of the B-C Loop of the Type III Repeat 8
por: Ventura, Elisa, et al.
Publicado: (2010)

The TLR4 Agonist Fibronectin Extra Domain A is Cryptic, Exposed by Elastase-2; use in a fibrin matrix cancer vaccine
por: Julier, Ziad, et al.
Publicado: (2015)

Gene editing of the extra domain A positive fibronectin in various tumors, amplified the effects of CRISPR/Cas system on the inhibition of tumor progression
por: Lv, Wan-Qi, et al.
Publicado: (2017)

Role of fibronectin in collagen deposition: Fab' to the gelatin-binding domain of fibronectin inhibits both fibronectin and collagen organization in fibroblast extracellular matrix
Publicado: (1982)

Irigenin, a novel lead from Western Himalayan chemiome inhibits Fibronectin-Extra Domain A induced metastasis in Lung cancer cells
por: Amin, Asif, et al.
Publicado: (2016)

Anti-Extra Domain B Splice Variant of Fibronectin Antibody–Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade
por: Hooper, Andrea T., et al.
Publicado: (2022)

Initiation of fibronectin fibrillogenesis is an enzyme-dependent process
por: Melamed, Shay, et al.
Publicado: (2023)

Case Study on the Maintenance of a Construction Monitoring Using USN-Based Data Acquisition
por: Kim, Sangyong, et al.
Publicado: (2014)

C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8
por: Ventura, Elisa, et al.
Publicado: (2016)

Noninvasive Identification of Viable Cell Populations in Docetaxel-Treated Breast Tumors Using Ferritin-Based Magnetic Resonance Imaging
por: Choi, YoonSeok, et al.
Publicado: (2013)

Extra and Intramedullary Anaplastic Ependymoma in Thoracic Spinal Cord
por: Kim, Byung Soo, et al.
Publicado: (2013)

The effect of fibronectin-coated implant on canine osseointegration
por: Kim, Sungtae, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jv6iqvgtl0g526rg39aq3crng5